or
forgot password
  • cancer clinical trials in columbus, OH

  • Creatine in Treating Patients With Cancer-Associated Weight Loss
    Grant Medical Center Cancer Care
    Columbus, Ohio 43215
    Anorexia, Cachexia, Unspecified Adult Solid Tumor, Protocol Specific, Weight Changes
    Xcellerated T CellsTM for Non-Hodgkin’s Lymphoma (NHL) Patients
    Ohio State University
    Columbus, Ohio 43210
    Non-Hodgkin's Lymphoma
    Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients With Non-Small-Cell Lung Carcinoma (NSCLC)
    Arthur G James Cancer Hospital and Richard Solove Research Institute at Ohio State University
    Columbus, Ohio 43210
    NSCLC
    Study of Late-Occurring Complications in Childhood Cancer Survivors
    Nationwide Children's Hospital
    Columbus, Ohio 43205-2696
    Cancer Survivor, Cardiovascular Complications, Hematopoietic/Lymphoid Cancer, Unspecified Childhood Solid Tumor, Protocol Specific
    Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck
    Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University
    Columbus, Ohio 43210-1240
    Head and Neck Cancer
    Decitabine and Valproic Acid in Treating Patients With Non-Small Cell Lung Cancer
    Ohio State University Medical Center
    Columbus, Ohio 43210
    Recurrent Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131
    Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
    Columbus, Ohio 43210-1240
    Recurrent Thyroid Cancer, Stage IVA Follicular Thyroid Cancer, Stage IVA Papillary Thyroid Cancer, Stage IVB Follicular Thyroid Cancer, Stage IVB Papillary Thyroid Cancer, Stage IVC Follicular Thyroid Cancer, Stage IVC Papillary Thyroid Cancer
    S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML
    CCOP - Columbus

    Trial Locations
    CCOP - Columbus
    Doctors Hospital at Ohio Health
    Riverside Methodist Hospital Cancer Care
    Mount Carmel Health - West Hospital
    Grant Medical Center Cancer Care
    Leukemia
    Ixabepilone in Treating Patients With Metastatic Prostate Cancer
    Doctors Hospital at Ohio Health

    Trial Locations
    Doctors Hospital at Ohio Health
    Riverside Methodist Hospital Cancer Care
    Mount Carmel Health - West Hospital
    Grant Medical Center Cancer Care
    Prostate Cancer
    Quality of Life in Postmenopausal Women Who Are Receiving Either Exemestane or Anastrozole With or Without Celecoxib for Stage I, Stage II, or Stage IIIA Primary Breast Cancer
    CCOP - Columbus

    Trial Locations
    CCOP - Columbus
    Doctors Hospital at Ohio Health
    Riverside Methodist Hospital Cancer Care
    Grant Riverside Cancer Services
    Mount Carmel West Hospital
    Breast Cancer
    Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
    CCOP - Columbus

    Trial Locations
    CCOP - Columbus
    Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University
    Doctors Hospital at Ohio Health
    Riverside Methodist Hospital Cancer Care
    Grant Riverside Cancer Services
    Mount Carmel Health - West Hospital
    Colorectal Cancer
    Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
    Doctors Hospital at Ohio Health

    Trial Locations
    Doctors Hospital at Ohio Health
    Riverside Methodist Hospital Cancer Care
    Mount Carmel Health - West Hospital
    Grant Medical Center Cancer Care
    Colorectal Cancer
    Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
    Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center
    Columbus, Ohio 43210-1240
    Breast Cancer
    Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy
    Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
    Columbus, Ohio 43210-1240
    Insular Thyroid Cancer, Recurrent Thyroid Cancer, Stage II Follicular Thyroid Cancer, Stage II Papillary Thyroid Cancer, Stage IV Follicular Thyroid Cancer, Stage IV Papillary Thyroid Cancer
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center

    Trial Locations
    Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
    Riverside Methodist Hospital
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Multiple Myeloma
    Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
    Columbus, Ohio 43210-1240
    Multiple Myeloma and Plasma Cell Neoplasm
    Temozolomide and Radiation Therapy in Treating Patients With Gliomas
    Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
    Columbus, Ohio 43210-1240
    Brain and Central Nervous System Tumors
    Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer
    CCOP - Columbus

    Trial Locations
    CCOP - Columbus
    Doctors Hospital at Ohio Health
    Riverside Methodist Hospital Cancer Care
    Mount Carmel Health - West Hospital
    Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center
    Grant Medical Center Cancer Care
    Breast Cancer
    Safety and Dose Study of GRN163L to Treat Patients With Chronic Lymphoproliferative Disease(CLD)
    The Ohio State University James Cancer Hospital
    Columbus, Ohio 43210
    Chronic Lymphoproliferative Diseases
    Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
    Nationwide Children's Hospital
    Columbus, Ohio 43205-2696
    Localized Osteosarcoma, Metastatic Osteosarcoma
    Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
    Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center
    Columbus, Ohio 43210-1240
    Metastatic Cancer, Prostate Cancer
    A Trial of Doxil and Multiday Vinorelbine in Patients With Metastatic Breast Cancer
    Hematology Oncology Consultants, Inc
    Columbus, Ohio 43235
    Metastatic Breast Cancer
    Acute Myeloid Leukemia T Cell Depletion to Improve Transplants in Adults With Acute Myeloid Leukemia
    Ohio State/Arthur G. James Cancer Hospital
    Columbus, Ohio 43210
    Leukemia, Myelocytic, Acute
    Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary
    Ohio State University
    Columbus, Ohio 43210
    Tumors, Unknown Primary Tumors, Adenocarcinoma
    Phase II Trial of Pentostatin in Steroid Refractory Acute Graft Versus Host Disease
    Ohio State University
    Columbus, Ohio 43210
    Graft-Versus-Host Disease
    A Phase II Study of Capecitabine and Docetaxel in Previously Untreated Advanced Non-Small Cell Lung Cancer Patients
    Ohio State University
    Columbus, Ohio 43210
    Lung Cancer, Non-Small-Cell Lung Carcinoma
    Vaccine Therapy, GM-CSF, and Interferon Alfa-2b in Treating Patients With Locally Advanced or Metastatic Cancer That Expresses Carcinoembryonic Antigen (CEA)
    Ohio State University Medical Center
    Columbus, Ohio 43210
    Unspecified Adult Solid Tumor, Protocol Specific
    Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer
    Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
    Columbus, Ohio 43210-1240
    Cervical Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center

    Trial Locations
    Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
    Riverside Methodist Hospital
    Adenocarcinoma of the Colon, Stage II Colon Cancer